Cargando…
Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys?
The advancements in our understanding of the inflammatory and immune mechanisms in rheumatoid arthritis (RA) have fuelled the development of targeted therapies that block cytokine networks and pathogenic immune cells, leading to a considerable improvement in the management of RA patients. Nonetheles...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416346/ https://www.ncbi.nlm.nih.gov/pubmed/25929877 http://dx.doi.org/10.1186/s13075-015-0634-1 |